Psychiatry Research
Volume 157, Issue 1 , Pages 95-104 , 15 January 2008

Long-chain n-3 polyunsaturated fatty acids decrease feelings of anger in substance abusers

Received 1 May 2006 ,Revised 4 September 2006 ,Accepted 5 January 2007.

References 

  1. Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reproduction, Nutrition, Development. 2004;44:509–538
  2. Berger GE, Smesny S, Amminger GP. Bioactive lipids in schizophrenia. International Review of Psychiatry. 2006;18:85–98
  3. Bradbury J, Myers SP, Oliver C. An adaptogenic role for omega-3 fatty acids in stress; a randomised placeb-controlled double blind intervention study (pilot). Nutrition Journal. 2004;3(20):1–10
  4. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed.. Hillsdale, NJ: Lawrence Erlbaum; 1988;
  5. de la Pressa Owens S, Innis SM. Diverse, region-specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and α-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatric Research. 2000;48:125–130
  6. Delion S, Chalon S, Guilloteau D, Besnard JC, Durand G. α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. Journal of Neurochemistry. 1996;66:1582–1591
  7. DeMar JC, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. Journal of Lipid Research. 2006;47:172–180
  8. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington, DC: American Psychiatric Press; 1997;
  9. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomized double-blind placebo-controlled study. British Journal of Psychiatry. 2006;188:46–50
  10. Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. British Journal of Psychiatry. 2002;181:22–28
  11. Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, et al. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. Journal of Clinical Investigation. 1996;97:1129–1133
  12. Hamazaki T, Sawazaki S, Nagao Y, Kuwamori T, Yazawa K, Mizushima Y, et al. Docosahexaenoic acid does not affect aggression of normal volunteers under nonstressful conditions. A randomized, placebo-controlled, double-blind study. Lipids. 1998;33:663–667
  13. Hamazaki T, Thienprasert A, Kheovichai K, Samuhaseneetoo S, Nagasawa T, Watanabe S. The effect of docosahexaenoic acid on aggression in elderly Thai subjects — a placebo-controlled double-blind study. Nutritional Neuroscience. 2002;5:37–41
  14. Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351:1213
  15. Hibbeln JR, Salem N. Omega-3 fatty acids and psychiatric disorders. Current status of the field. In:  Mostofosky D,  Yehuda S,  Salem N editor. Fatty Acids: Physiological and Behavioral Functions. Totowa, NJ: Humana Press; 2001;p. 311–330
  16. Hibbeln JR, Linnoila M, Umhau C, Rawlings R, George DT, Salem N. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biological Psychiatry. 1998;44:235–242
  17. Hibbeln JR, Nieminen LRG, Blasbalg TL, Riggs JA, Lands WEM. Healthy intakes of omega-3 and omega-6 fatty acids: estimations considering worldwide diversity. American Journal of Clinical Nutrition. 2006;83(suppl):1483S–1493S
  18. Holub BJ. Clinical nutrition, 4: omega-3 fatty acids in cardiovascular care. Canadian Medical Association Journal. 2002;166:608–615
  19. International Society for the Study of Fatty Acids and Lipids . Recommendations for Dietary Intake of Polyunsaturated Fatty Acids in Healthy Adults. 2004;Report presented at the 6th ISSFAL Congress, Brighton, UK
  20. Irribaren C, Markovitz JH, Jacobs DR, Schreiner PJ, Daviglus M, Hibbeln JR. Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults — the CARDIA study. European Journal of Clinical Nutrition. 2004;58:24–31
  21. Kodas E, Galineau L, Bodard S, Vancassel L, Guilloteau D, Besnard JC, et al. Serotonergic transmission is affected by n-3 polyunsaturated fatty acids in the rat. Journal of Neurochemistry. 2004;89:695–702
  22. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation. 2002;106:2747–2757
  23. Maes M, Smith RS. Fatty acids, cytokines, and major depression. Biological Psychiatry. 1998;43:313–314
  24. Mann JJ. Violence and aggression. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 1919–1928
  25. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. American Journal of Psychiatry. 2003;160:996–998
  26. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
  27. McNair DM, Lorr M, Droppleman LF. Manual for the Profile of Mood States. San Diego: Educational Testing Service; 1971;
  28. Merikangas KR, Metha RL, Molnar BE, Walter EE, Swendsen JD, Aguilar-Gaziola S, et al. Comorbidity of substance use disorder with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology. Addictive Behaviors. 1998;23:893–907
  29. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depression disorder. American Journal of Psychiatry. 2002;159:477–479
  30. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. American Journal of Psychiatry. 2006;163:1098–1100
  31. Olsson NU, Shoaf SE, Salem N. The effect of dietary polyunsaturated fatty acids and alcohol on neurotransmitters levels in rat brain. Nutritional Neuroscience. 1998;1:133–140
  32. Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. American Journal of Psychiatry. 2006;163:969–978
  33. Peet M. Nutrition and schizophrenia. World Review of Nutrition and Dietetics. 2005;95:17–28
  34. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite adequate treatment with standard drugs. Archives of General Psychiatry. 2002;59:913–919
  35. Puri BK, Counsell SJ, Hamilton G, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. International Journal of Clinical Practice. 2001;55:560–563
  36. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology. 2006;27:24–31
  37. Stanley M, Mann JJ. Increased serotonin 2 binding sites in frontal cortex of suicide victims. Lancet. 1983;8318:214–216
  38. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, et al. Omega-3 fatty acids in bipolar disorder: a preliminary, double-blind, placebo-controlled trial. Archives of General Psychiatry. 1999;56:407–412
  39. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology. 2003;13:267–271
  40. Virkkunen ME, Horrobin DF, Jenkins DK, Manku MS. Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders. Biological Psychiatry. 1987;22:1087–1096
  41. Young GS, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reproduction, Nutrition, Development. 2005;45:1–28
  42. Zanarini MC, Frankenburg FR. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. American Journal of Psychiatry. 2003;160:167–169

PII: S0165-1781(07)00006-6

doi: 10.1016/j.psychres.2007.01.004

Psychiatry Research
Volume 157, Issue 1 , Pages 95-104 , 15 January 2008

Article Tools

* Image Usage & Resolution